12.07.2015 Views

Read the Registration Document - Guerbet

Read the Registration Document - Guerbet

Read the Registration Document - Guerbet

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Note 13 – Sales by region2012 2011France (including overseas department and territories) 123,445 108,958Europe excluding France 104,316 105,492Europe including France 227,761 214,450Asia 27,271 26,031Latin America 24,188 26,083North America 7,115 9,798O<strong>the</strong>r countries 14,360 14,643Total 300,695 291,005Note 14 – Operating grantsIn December 2008, <strong>the</strong> request for aid submitted to OSEO innovation agency for <strong>the</strong> Franco-Germanresearch project, Iseult, was approved by <strong>the</strong> European commission. The aid agreement provides forfinancing for one half of <strong>the</strong> expenses incurred including 39% in <strong>the</strong> form of repayable advances and 61% in<strong>the</strong> form of grants.At 31 December 2012, <strong>the</strong> following items were recognised in connection with this aid agreement:In <strong>the</strong> balance sheet:- €2.3 million in grants received prior to <strong>the</strong> signature of <strong>the</strong> agreement in December 2008 andrecognised under "O<strong>the</strong>r current financial liabilities";- €1.8 million in repayable advances received from 2008 to 2011 and recognised under "Non-currentfinancial liabilities".- €1.4 million in grants receivable for research expenditures incurred by <strong>Guerbet</strong> from 1 July 2011 to30 June 2012. These grants are recognised under "O<strong>the</strong>r current financial assets".In <strong>the</strong> income statement:- €1.4 million recognised under "O<strong>the</strong>r revenue from ordinary activities" for this grant receivable.A €1.6 million repayable advance to be received in 2013 by <strong>Guerbet</strong> for research expenditures incurredfrom July 2011 to June 2012. This item was not recognised in <strong>the</strong> financial statements at 31 December2012.In 2011, <strong>Guerbet</strong> received and recognised financing of €2.5 million including €2.4 million in grants and €0.1million in repayable advances for research expenditures incurred by <strong>Guerbet</strong> from July 2010 to June 2011.The amount of contingent income that remains to be received for research expenditures incurred in <strong>the</strong>2012 second half but not yet approved by Oseo at <strong>the</strong> end of <strong>the</strong> reporting period and not recognised in <strong>the</strong>income statement would amount to €503,000 in grants. To this, €325,000 in repayable advances should beadded.An amendment is in <strong>the</strong> process of being executed with Oseo that provides for a two-year extension of <strong>the</strong>term of <strong>the</strong> project and a modification of <strong>the</strong> terms for financial returns in <strong>the</strong> eventuality a product is put on<strong>the</strong> market on completion of <strong>the</strong> project.Note 15 – O<strong>the</strong>r incomeAn insurance payment of €3.3 million was paid for material damage and business interruption losses for <strong>the</strong>claim of November 2011 involving our Lanester site.127

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!